|

Voice-based Outcome Identification and Clinical Evaluation in Heart Failure

RECRUITINGSponsored by Noah Labs
Actively Recruiting
SponsorNoah Labs
Started2026-10-15
Est. completion2027-12
Eligibility
Age22 Years+
Healthy vol.Accepted
Locations1 site

Summary

VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.

Eligibility

Age: 22 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥22
* HF diagnosis (Stage C)
* DHF event within prior 180 days

Exclusion Criteria:

* Monitoring with implantable volume or pressure monitoring devices, or
* Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or
* Otherwise inability or unwillingness to comply with study procedures.

Conditions4

Chronic Heart DiseaseChronic Heart FailureHeart DiseaseHeart Failure

Locations1 site

Brigham and Women's Hospital
Ameesh Isath, MBBS617-732-6237aisath@bwh.harvard.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.